维持性腹膜透析患者微炎症状态的研究被引量：9

下载PDF

导出

摘要腹膜透析（PD）因其保护残余肾功能、血流动力学相对稳定、操作简便等优点在临床上应用越来越广泛。但PD患者普遍存在的微炎症状态,其发生率在70%以上[1],持续的微炎症状态可引起动脉粥样硬化、心肌肥厚及心力衰竭、蛋白质能量消耗等病理生理改变[2-3]。故微炎症状态与PD患者的心血管事件发生率、死亡率密切相关,已成为影响PD患者预后的重要因素[4-5]。

作者李小平冯曦

机构地区南京医科大学附属常州第二人民医院肾内科

出处《实用临床医药杂志》 CAS 2016年第21期197-199,共3页 Journal of Clinical Medicine in Practice

关键词日间非卧床腹膜透析腹膜透析微炎症

分类号 R459.5 [医药卫生—治疗学]

引文网络
相关文献

参考文献1

1Ji-Chao Guan,Wei Bian,Xiao-Hui Zhang,Zhang-Fei Shou,Jiang-Hua Chen.Influence of Peritoneal Transport Characteristics on Nutritional Status and Clinical Outcome in Chinese Diabetic Nephropathy Patients on Peritoneal Dialysis[J].Chinese Medical Journal,2015(7):859-864. 被引量：31

二级参考文献24

1Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA2013;310:948-59.
2Zuo L, Wang M, Chinese Association of Blood Purification Management ofChinese Hospital Association. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 2010;74 Suppl 1 :S20-2.
3Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998;9:1285-92.
4Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006;17:271-8.
5Brimble K.S, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-analysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006;17:2591-8.
6Lee CC, Chen KH, Tian YC, Weng CM, Yang CW, Hung CC. Initial high peritoneal transport status is not a predictor of mortality in peritoneal dialysis patients. Ren Fail 2010;32:788-95.
7Perl J. Huckvale K, Chellar M, John B, Davies SJ. Peritoneal protein clearance and not peritoneal membrane transport status predictssurvival in a contemporary cohort of peritoneal dialysis patients. Clin J Am Soc Nephrol 2009;4:1201-6.
8Reyes MJ, Bajo M A, Hevia C, Del Peso G, Ros S, de Miguel AG, et al. Inherent high peritoneal transport and ultrafiltration deficiency: Their mid-term clinical relevance. Nephrol Dial Transplant 2007;22:218-23.
9Ozener C, Arikan H, Karayaylali I, Utas C, Bozfakioglu S, Akpolat T, et al. The impact of diabetes mellitus on peritoneal dialysis: The Turkey Multicenter Clinic Study. Ren Fail 2014;36:149-53.
10UnsalA, KocY, BasturkT, Sakaci T,AhbapE, Sinangil A, etal. Clinical outcomes and mortality in peritoneal dialysis patients: A 10-year retrospective analysis in a single center. Clin Nephrol 2013;80:270-9.